The failure of “engineered rejuvenation”: laboratory genomics do not translate into precision anti-aging therapies

Abstract

There is a general failure of reductionist and mechanistic approaches to rejuvenation biomedical technologies which aim at providing treatments against aging (defined as “time-dependent dysfunction”). Importantly, it is becoming increasingly recognised that genomic research findings in animals may not adequately be translated into effective human anti-aging therapies. There exist translational impediments, which although individually formidable, can theoretically be overcome. However, the combined effects of these obstacles render this reductionist avenue of quest unattainable, at least for the foreseeable future. Some of the clinical problems of physical and genomic-based therapies against aging include side effects, interactions, inter-subject variability, compliance, patient self-reporting of data, motivation, administrative issues, infrastructure, etc. A systematic review spanning over the past 5 years, describes these problems and identifies novel approaches. New and emerging disciplines and concepts such as molecular pathological epidemiology, social genomics and other “systems-thinking” methods provide a more comprehensive view of the entire subject of aging, and study its indivisible bonds with the environment, society and culture. The so-called “fountain of youth” cannot be found in a physical item.

Keywords

Reductionism / rejuvenation biotechnologies / genomic research / translation / systems-thinking / molecular pathological epidemiology

References

[1] Liu JP.Molecular mechanisms of ageing and related diseases.Clin Exp Pharmacol Physiol2014;41:445-58

[2] Goldsmith TC.Evolution of aging theories: why modern programmed aging concepts are transforming medical research.Biochemistry (Mosc)2016;81:1406-12

[3] Vaiserman AM.Aging-modulating treatments: from reductionism to a system-oriented perspective.Front Genet2014;5:446 PMCID:PMC4271728

[4] Kyriazis M.Third phase science: defining a novel model of research into human ageing.Front Biosci (Landmark Ed)2017;22:982-90

[5] Kyriazis M.Editorial: Re-thinking ageing: a cross-disciplinary perspective (a new era for ageing).Mech Ageing Dev2017;163:1

[6] Cabrera D.Systems thinking made simple: new hope for solving wicked problem..Ithaca, NY: Odyssean;2015;

[7] Asensio-Sánchez VM.Dracula was right: the elixir of youth could be the young blood.Arch Soc Esp Oftalmol2015;90:453

[8] Elghblawi E.Platelet-rich plasma, the ultimate secret for youthful skin elixir and hair growth triggering.J Cosmet Dermatol2018;17:423-30

[9] Girgis CM.Vitamin D and muscle function in the elderly: the elixir of youth? Curr Opin Clin Nutr Metab Care 2014;17:546-50.Curr Opin Clin Nutr Metab Care2014;17:546-50

[10] Andersen RE.An ingredient for the elixir of youth.Cell Res2014;24:1381-2 PMCID:PMC4260342

[11] Check Hayden E.Anti-ageing pill pushed as bona fide drug.Nature2015;522:265-6

[12] Bhullar KS.Lifespan and healthspan extension by resveratrol.Biochim Biophys Acta2015;1852:1209-18

[13] Kumar S.Finding Ponce de Leon's Pill: challenges in screening for anti-aging molecules.F1000Res2016;5:F1000 Faculty Rev-406

[14] Cottin Y.A member of the TGF-β superfamily, GDF11: functions in the cardiac regeneration, perhaps an "elixir of youth?".Arch Cardiovasc Dis2015;108:409-11

[15] Lucke JC,Partridge B.Anticipating the anti-ageing pill. Lessons from the history of the oral contraceptive pill and hormone replacement therapy..EMBO Rep2009;10:108-13 PMCID:PMC2637320

[16] Wagner G.Towards a life prolonging pill? Small molecules with anti-ageing properties. Small molecules with anti-ageing properties..Curr Drug Targets2006;7:1531-7

[17] Blagosklonny MV.An anti-aging drug today: from senescence-promoting genes to anti-aging pill.Drug Discov Today2007;12:218-24

[18] Zealley B.Commentary on some recent theses relevant to combating aging: February 2018.Rejuvenation Res2018;21:70-6

[19] Kyriazis M.The fallacy of the longevity elixir: negligible senescence may be achieved, but not by using something physical.Curr Aging Sci2015;8:227-34

[20] Kyriazis M.The impracticality of biomedical rejuvenation therapies: translational and pharmacological barriers.Rejuvenation Res2014;17:390-6 PMCID:PMC4142774

[21] Callahan CM,Saykin AJ,Hendrie HC.Translational research on aging: clinical epidemiology as a bridge between the sciences.Transl Res2014;163:439-45 PMCID:PMC4012418

[22] Henney AM.The promise and challenge of personalized medicine: aging populations, complex diseases, and unmet medical need.Croat Med J2012;53:207-10 PMCID:PMC3368289

[23] de Magalhães JP.The scientific quest for lasting youth: prospects for curing aging.Rejuvenation Res2014;17:458-67 PMCID:PMC4203147

[24] Mohler J,Fain M.Precision medicine: a wider definition.J Am Geriatr Soc2015;63:1971-2

[25] Reitz C.Toward precision medicine in Alzheimer's disease.Ann Transl Med2016;4:107 PMCID:PMC4828743

[26] Hampel H,Castrillo JI,Rojkova K,Benda N,Frank RA,Escott-Price V.Precision medicine - the golden gate for detection, treatment and prevention of Alzheimer's disease.J Prev Alzheimers Dis2016;3:243-59 PMCID:PMC5363725

[27] Zhu Y,Pirtskhalava T.The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.Aging Cell2015;14:644-58 PMCID:PMC4531078

[28] Roos CM,Palmer AK.Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice.Aging Cell2016;15:973-7 PMCID:PMC5013022

[29] Zhu Y,Fuhrmann-Stroissnigg H.Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.Aging Cell2016;15:428-35 PMCID:PMC4854923

[30] Rahnasto-Rilla M,Huovinen M,Kulikowicz T,A Bohr V,Lahtela-Kakkonen M.Natural polyphenols as sirtuin 6 modulators.Sci Rep2018;8:4163 PMCID:PMC5841289

[31] Kraig E,Liang H,Liu Q,Benavides AD,Javors MA,Chiodo L,Gelfond JAL.A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.Exp Gerontol2018;105:53-69

[32] Ratho L,Awasthi H.An antidiabetic polyherbal phytomedicine confers stress resistance and extends lifespan in Caenorhabditis elegans.Biogerontology2017;18:131-47

[33] Barzilai N,Kritchevsky SB.Metformin as a tool to target aging.Cell Metab2016;23:1060-5 PMCID:PMC5943638

[34] Strazhesko ID,Akasheva DU.Atorvastatin therapy modulates telomerase activity in patients free of atherosclerotic cardiovascular diseases.Front Pharmacol2016;7:347 PMCID:PMC5043056

[35] Kyriazis M.Translating laboratory anti-aging biotechnology into applied clinical practice: problems and obstacles.World J Transl Med2015;4:51-4

[36] Joyner MJ.Precision medicine, cardiovascular disease and hunting elephants.Prog Cardiovasc Dis2016;58:651-60

[37] MacRae CA.Closing the phenotype gap in precision medicine.Circulation2016;133:2634-9

[38] Bausch KC.The Theory and Practice of Third Phase Science..In: Metcalf G, editor. Social Systems and Design.2014;Springer, TokyoTranslational Systems Sciences

[39] Olshansky SJ.Is life extension today a faustian bargain?.Front Med (Lausanne)2017;4:215 PMCID:PMC5712535

[40] Ι Barat,Damsgaard EMS.Drug therapy in the elderly: what doctors believe and patients actually do.Br J Clin Pharmacol2001;51:615-22 PMCID:PMC2014493

[41] Tang HY,Weissinger G.The role of depression in medication adherence among heart failure patients.Clin Nurs Res2014;23:231-44 PMCID:PMC4130342

[42] Donadiki EM,Hernández-Barrera V.Health belief model applied to non-compliance with HPV vaccine among female university students.Public Health2014;128:268-73

[43] Ehrlich S, Newkirk T, Pallas S, Riedinger T, Jackson D. Why are patients with chronic disease nonadherent with their prescription medications? Proceeding of American Academy of Physician Assistants 2017 conference; 2017 May 15-19; Las Vegas, USA

[44] Pasina L,Falcone C,Bresciani A,Taddei GC,Franchi C,Nobili A.Medication non-adherence among elderly patients newly discharged and receiving polypharmacy.Drugs Aging2014;31:283-9

[45] Mukhtar O,Jackson SH.Intentional non-adherence to medications by older adults.Drugs Aging2014;31:149-57

[46] Shepherd JG,Zhang Q.Health services use and prescription access among uninsured patients managing chronic diseases.J Community Health2014;39:572-83

[47] Domingue BW.The social genome: current findings and implications for the study of human genetics.PLoS Genet2017;13:e1006615 PMCID:PMC5354246

[48] Cole SW.Human social genomics.PLoS Genet2014;10:e1004601 PMCID:PMC4148225

[49] Portin P.A comparison of biological and cultural evolution.J Genet2015;94:155-68

[50] Creanza N,Feldman MW.Cultural evolutionary theory: how culture evolves and why it matters..Proc Natl Acad Sci U S A2017;

[51] Zierer J,Kastenmüller G.Integration of 'omics' data in aging research: from biomarkers to systems biology.Aging Cell2015;14:933-44 PMCID:PMC4693464

[52] Kyriazis M.Technological integration and hyper-connectivity: tools for promoting extreme human lifespans.Complexity2014;20:15-24

[53] Kyriazis M.Reductionism versus Systems Thinking in Aging Research.In: Ahmad S. editor, Aging: Exploring a complex phenomenon. Boca Raton: CRC Press;2018; PMCID:PMC5796895

[54] Ogino S,Chan AT.Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.Mod Pathol2013;26:465-84 PMCID:PMC3637979

[55] Ogino S,Giovannucci E.How many molecular subtypes? Implications of the unique tumor principle in personalized medicine. Implications of the unique tumor principle in personalized medicine..Expert review of molecular diagnostics2012;12:621-8 PMCID:PMC3492839

[56] Schully SD.What is translational genomics? An expanded research agenda for improving individual and population health. An expanded research agenda for improving individual and population health..Appl Transl Genom2014;3:82-3 PMCID:PMC4694629

[57] Heneghan C,Mahtani KR.Why clinical trial outcomes fail to translate into benefits for patients.Trials2017;18:122 PMCID:PMC5348914

[58] Abernethy AP.True translational research: bridging the three phases of translation through data and behavior.Translational Behav Med2011;1:26-30 PMCID:PMC3717703

[59] London AJ.Why clinical translation cannot succeed without failure.eLife2015;4:e12844 PMCID:PMC4657068

[60] Marusic U.Non-physical approaches to counteract age-related functional deterioration: applications for rehabilitation and neural mechanisms.Eur J Sport Sci2018;20:1-11

[61] Amendola LM,Hart R,Lee K,East K,Kauffman TL,Roche M,Wynn J.Why patients decline genomic sequencing studies: experiences from the CSER consortium.J Genet Couns2018;

[62] Wolf SM,Koenig BA.Mapping the ethics of translational genomics: situating return of results and navigating the research-clinical divide.J Law Med Ethics2015;43:486-501 PMCID:PMC4620583